Recruiting Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma NCT07156227 Conditions Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +48 more Locations UPMC Hillman Cancer Center LAO — Pittsburgh, Pennsylvania, United States View Trial Details
Active, Not Recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer NCT04576091 Conditions Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more Locations Los Angeles General Medical Center — Los Angeles, California, United States USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States Northwestern University — Chicago, Illinois, United States University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States View more locations Show fewer locations Loading locations... View Trial Details
